antibody characterization

Precision Antibody, a brand of A&G Pharmaceutical Inc., provides custom antibody development services with over 20 years of experience. The company develops mouse and rat monoclonal antibodies, fully human monoclonal antibodies, humanized antibodies, and polyclonal antibodies, and offers antibody production, purification, and characterization for pharmaceutical, biotech, academic, and federal laboratory clients.

antibody humanizationantibody productionantibody purificationconjugationcustom antibody developmentcustom EIAepitope mappingflow based assaysIHCinternalization assaysmammalian cell bankingmonoclonal antibody developmentneutralization assaysOctet and Biacore binding analysispolyclonal antibody developmentrecombinant IgG expressionVH/VL sequencing

CeleramAb Inc. is a Madison, Wisconsin biotechnology company founded in October 2024 by Professors Joshua Coon and Lloyd Smith under an exclusive license agreement with the Wisconsin Alumni Research Foundation (WARF). It develops the RaPiD-mAb-MS™ platform to accelerate antibody characterization and peptide mapping by eliminating the traditional liquid chromatography bottleneck, claiming a 50X throughput increase and >2X cost reduction.

automated data analysismass spectrometrypeptide mappingproteomics

Immunartes is a biotechnology company developing therapies that neutralize Staphylococcus aureus immune evasion to restore host defense and prevent serious S. aureus disease. Its platform targets the immune-evasion pathway and supports coordinated vaccine and monoclonal antibody (mAb) programs aimed at prevention, currently in preclinical discovery and IND-enabling stages.

animal modelsmonoclonal antibody developmentpreclinical researchtranslational immunologyvaccine antigen evaluationvaccine development